Follow The Filings

MNTS Momentus

Momentus earnings company data as of 4:49 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 18 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by MNTS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MNTS insider trades
  • $35K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Chris Hadfield Director
    Buy
    $14K 2,000 shares at $7.19 +133% to stake
    Traded May 21 Filed May 26
  2. Brian Kabot Director
    Buy
    $1,379 250 shares at $5.52 +5.6% to stake
    Traded May 20 Filed May 22
  3. Brian Kabot Director
    Buy
    $1,404 250 shares at $5.62 +5.9% to stake
    Traded May 19 Filed May 20
  4. Brian Kabot Director
    Buy
    $9,999 1,850 shares at $5.40 +128% to stake
    Traded May 15 Filed May 20
  5. Chris Hadfield Director
    Buy
    $7,980 1,500 shares at $5.32 New stake
    Traded May 15 Filed May 18

Also filed in the last 12 months, not counted as buying or selling: 5 option exercises and 4 stock grants.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 1.02
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 4.01,9.01
10-Q
424B5
8-K 8.01,9.01
424B5
8-K 1.01,7.01,9.01
8-K 1.01,3.02,7.01,9.01
SCHEDULE 13G —
8-K 5.07,9.01
SCHEDULE 13G —
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G —
8-K 1.02
8-K 1.01,3.02,7.01,9.01
8-K 8.01,9.01
DEF 14A
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.